Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced that the first patient in its Phase I/II clinical trial with RV-001 has been ...
Discover how UC Merced's Nicotine and Cannabis Policy Center uses wastewater analysis to track nicotine use in California's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback